Clinical Trial Update: Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites [Phase 2]

View source ↗

Summary

Phase 2 dose-exploration study of tolvaptan for hepatic cirrhosis with ascites has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Hepatic Cirrhosis

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Ascites, Hepatic Cirrhosis | Phase 2 | Status: COMPLETED